AREV Life Sciences Global Corp. (AREVF) Research

AREV Life Sciences Global Corp., a Canadian-based integrated life science company founded in 2005 in Coquitlam, specializes in the discovery, production, and distribution of functional ingredients. The company, which rebranded from AREV NanoTec Brands Inc. in August 2021, offers a diverse range of products. Its portfolio features various CBD-infused items, including the antiviral supplements Canna-Mulsion and NaturVax, the natural sleep aid NaturRelax, and the anti-inflammatory and pain relief product Natur Relief. AREV also supplies white-label cannabis products, a selection of THC-based offerings, cannabis skincare lines, medicinal oils, and edibles. The ingredients developed by AREV are incorporated into products intended for a wide array of markets, such as natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical sectors. These offerings are designed to alleviate health concerns including sleep deprivation, insomnia, anxiety, pain, inflammatory conditions, and other specific ailments. Furthermore, the company markets nutraceutical formulations under its Bare brand and provides ready-to-use therapeutic food products under the SUS-TAINN name.

Market snapshot

Symbol
AREVF
Price
$0.00
Day change
0.00%
Market cap
$2.8M
P/E ratio
-1.87x
52-week range
0.0005-0.01
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aoxing Pharmaceutical Company, Inc. (AOXG)
  • CannAmerica Brands Corp. (CNNXF)
  • Plant-Based Investment Corp. (CWWBF)
  • Global Hemp Group Inc. (GBHPF)
  • Groove Botanicals, Inc. (GRVE)
  • Indoor Harvest Corp (INQD)
  • Industry Source Consulting, Inc. (INSO)
  • Legacy Technology Holdings, Inc. (LTHO)

Open AREV Life Sciences Global Corp. (AREVF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.